医院药事

北京协和医院静脉药物配置中心实时审核干预不合理医嘱分析及对策

展开
  • 中国医学科学院-北京协和医学院, 北京协和医院, 北京100730

网络出版日期: 2020-02-05

基金资助

中国医学科学院医学与健康科技创新工程项目资助(编号2017-12M-1-011)

Analysis of Real-time Reviews and Intervention on Irrational Medical Orders in Pharmacy Intravenous Admixture Services in Peking Union Medical College and the Countermeasures Hospital

Expand
  • Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China

Online published: 2020-02-05

摘要

目的:分析北京协和医院静脉药物配置中心实时干预的不合理医嘱,并探讨解决对策。方法:回顾性统计2018年我院静脉药物配置中心审方药师根据《临床药物治疗学》、药品说明书、MICROMEDEX及Up To Date等相关资料对长期医嘱和临时医嘱进行实时前置审核所发现的不合格医嘱类型与数量,计算干预率。结果:从实时审核医嘱中共发现不合理医嘱174份,主要涉及药物用法用量不适宜、录入错误、溶媒不适宜及药物浓度不适宜等,干预率达100%。结论:通过静脉药物配制中心药师对医嘱的实时审核和干预,能有效地降低和避免不合理用药的产生,促进临床合理用药。

本文引用格式

李杏翠, 焦蕾, 张凡, 赵彬, 徐小薇 . 北京协和医院静脉药物配置中心实时审核干预不合理医嘱分析及对策[J]. 中国药事, 2020 , 34(1) : 82 -87 . DOI: 10.16153/j.1002-7777.2020.01.013

Abstract

Objective: To analyze the irrational medical orders in pharmacy intravenous admixture services discovered by real-time reviews and intervened in by the pharmacists and to put forward and discuss the countermeasures. Methods: Pharmacists from the pharmacy intravenous admixture services audit long-term and temporary medical orders every day before mixing. Irrational medical orders were intervened in by the pharmacists. Based on Clinical Drug Therapeutics, pharmaceutical instructions, MICROMEDEX, Up To Date and so on, irrational medical orders in 2018 were analyzed retrospectively and statistically. The intervention rate was calculated. Results: A total of 174 irrational medical orders were intervened in by the pharmacists in 2018. The irrationality types mainly included unsuitable dosage and usage, entry error, improper selection of solvent type, improper drug concentration and so on. The intervention rate was 100%. Conclusion: Proper reviews and intervention from the PIVAS can effectively reduce and avoid the irrational drug use so as to promote the clinical safety and rational use of drugs.

参考文献

[1] 梅丹,于健春.临床药物治疗学.营养支持治疗[M].北京:人民卫生出版社,2017:21-31.
[2] 申慧彬,牛厚菊.静脉配置中心全静脉营养液的医嘱分析[J].中国药物与临床,2016,16(11):1677-1680.
[3] 李宁,于健春,蔡威.临床肠外肠内营养支持治疗学[M].北京:中华医学电子音像出版社,2012:394-492.
[4] Driscoll DF, Bhargava HN, Li L, et al. Physicochemical Stability of Total Nutrient Admixtures[J]. Am J Health Syst Pharm,1995,52:623-634.
[5] Allen LV. Remington:The Science and Practice of Pharmacy[M]. 22nd ed. Philadelphia:Pharmaceutical Press,2014:2267-2268.
[6] 赵彬,梅丹,陈伟.药学干预在规范肠外营养处方及预防差错中的作用[J].中华临床营养杂志,2014,22(3):167-170.
[7] 林淑恒,刘初阳,杨丽君.静脉输液配置中心不合理用药分析[J].牡丹江医学院学报,2014,35(4):148-149.
[8] 佘仕桂,刘青青.我院静脉药物配置中心输液不合理处方分析[J].中国药业,2014,23(18):67-68.
[9] 高文桂,杨一昆,普绍平,等.铂(Ⅱ)类抗癌药物的溶液化学反应特性[J].贵金属,2001,22(4):54-59.
[10] 陈来珍,尹媛,陆赟.静脉配置中心配置药物的优势分析[J].基层医学论坛,2018,22(29):4177-4188.
[11] 钱映惜.静脉药物配置中不合理配伍分析[J].临床合理用药,2018,11(11):107-108.
Options
文章导航

/